Valley Brook Capital Group Inc. Has $450,000 Position in Colgate-Palmolive (NYSE:CL)

Valley Brook Capital Group Inc. lessened its holdings in Colgate-Palmolive (NYSE:CL) by 4.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,648 shares of the company’s stock after selling 248 shares during the period. Valley Brook Capital Group Inc.’s holdings in Colgate-Palmolive were worth $450,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. FMR LLC boosted its position in Colgate-Palmolive by 27.3% during the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company’s stock worth $398,055,000 after acquiring an additional 1,199,660 shares during the period. AEGON ASSET MANAGEMENT UK Plc acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $62,728,000. Assenagon Asset Management S.A. boosted its position in Colgate-Palmolive by 92.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,436,054 shares of the company’s stock worth $114,468,000 after acquiring an additional 688,733 shares during the period. Envestnet Asset Management Inc. boosted its position in Colgate-Palmolive by 225.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 930,072 shares of the company’s stock worth $66,137,000 after acquiring an additional 644,205 shares during the period. Finally, Bank of Nova Scotia boosted its position in Colgate-Palmolive by 188.5% during the 3rd quarter. Bank of Nova Scotia now owns 883,272 shares of the company’s stock worth $62,809,000 after acquiring an additional 577,114 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders sold a total of 159,048 shares of company stock worth $13,336,846 over the last three months. 0.34% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CL shares. UBS Group raised their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. The Goldman Sachs Group began coverage on Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price target for the company. Bank of America raised their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. Evercore ISI raised their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Finally, StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $91.44.

Colgate-Palmolive Stock Performance

Shares of CL stock traded down $0.03 during trading hours on Friday, reaching $92.88. 5,432,695 shares of the company’s stock were exchanged, compared to its average volume of 4,878,342. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $93.25. The stock has a market capitalization of $76.20 billion, a P/E ratio of 29.39, a P/E/G ratio of 3.43 and a beta of 0.40. The business has a fifty day moving average price of $88.35 and a 200-day moving average price of $82.35. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the previous year, the company earned $0.73 earnings per share. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Analysts predict that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.